Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica

• Rolando Herrero ,

  * E-mail: herreror@iarc.fr

  Affiliation Prevention and Implementation Group, International Agency for Research on Cancer, Lyon, France

  ⨯
• Wim Quint,

  Affiliation DDL Diagnostic Laboratory, Rijswijk, The Netherlands

  ⨯
• Allan Hildesheim,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Paula Gonzalez,

  Affiliation Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, Guanacaste, Costa Rica

  ⨯
• Linda Struijk,

  Affiliation DDL Diagnostic Laboratory, Rijswijk, The Netherlands

  ⨯
• Hormuzd A. Katki,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Carolina Porras,

  Affiliation Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, Guanacaste, Costa Rica

  ⨯
• Mark Schiffman,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Ana Cecilia Rodriguez,

  Affiliation Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, Guanacaste, Costa Rica

  ⨯
• Diane Solomon,

  Affiliation Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Silvia Jimenez,

  Affiliation Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, Guanacaste, Costa Rica

  ⨯
• John T. Schiller,

  Affiliation Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Douglas R. Lowy,

  Affiliation Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Leen-Jan van Doorn,

  Affiliation DDL Diagnostic Laboratory, Rijswijk, The Netherlands

  ⨯
• Sholom Wacholder,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Aimée R. Kreimer,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
•  [ ... ],
• for the CVT Vaccine Group

  ¶¶Membership of the CVT Vaccine Group is provided in the Acknowledgments

  ⨯
• [ view all ]
• [ view less ]